Angeliki Thanasopoulou

Author

University Children’s Hospital Basel

Also Known As

A. Thanasopoulou, Angeliki Thanasopoulou

Publications

898

Citations

H-Index

Concepts

All Affiliations

University Children’s Hospital Basel University of Basel National and Kapodistrian University of Athens Academy of Athens

About

Angeliki Thanasopoulou is an author at University Children’s Hospital Basel specializing in cell biology, cancer research, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	407
2	Cell Biology	5	5	407
3	Health Sciences	2	2	85
4	Immunology	2	2	125
5	Natural Sciences	1	1	244

Angeliki Thanasopoulou

Publications

870

Citations

H-Index

Page 1

	Year	Citations
PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains S. Picaud, David Da Costa, Angeliki Thanasopoulou, Cancer Research Histone ModificationsChemoprevention StrategyBet BrdsMolecular BiologyBet Proteins	2013	244
Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease Randall J. Bateman, Janice Smith, Michael Donohue, New England Journal of Medicine	2023	239
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy S. Picaud, O. Fedorov, Angeliki Thanasopoulou, Cancer Research	2015	224
Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction Angeliki Thanasopoulou, Alexandar Tzankov, Juerg Schwaller Haematologica Mixed-phenotype Acute LeukemiaImmunologyTumor BiologyMyeloid NeoplasiaHematological Malignancy	2014	65
Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia Jarno Kivioja, Angeliki Thanasopoulou, Ashwini Kumar, Leukemia Hematological MalignancyMedicineMalignant Blood DisorderImmunologyNavitoclax Act	2018	60
Loss of CCDC6 Affects Cell Cycle through Impaired Intra-S-Phase Checkpoint Control Angeliki Thanasopoulou, Dimitrios J. Stravopodis, Konstantinos Dimas, PLoS ONE Cell DeathCell ProliferationEtoposide TreatmentCell CycleCcdc6 Gene Rearrangements	2012	20
Thymidylate synthase inhibition induces p53-dependent and p53-independent apoptotic responses in human urinary bladder cancer cells Dimitrios J. Stravopodis, Panagiotis K. Karkoulis, Eumorphia G. Konstantakou, Journal of Cancer Research and Clinical Oncology UrologyGenitourinary CancerOncogenic AgentCell DeathThymidylate Synthase Inhibition	2010	18

Page 1